Literature DB >> 17288898

[Epidemiology of sarcoidosis].

Estrella Fernández Fabrellas1.   

Abstract

Sarcoidosis is a multisystemic disease in which lung involvement is common. Its incidence and prevalence have been extensively studied, but with contradictory results because of the lack of standard diagnostic criteria, variations in the methods for detecting cases, and the low sensitivity and specificity of diagnostic tests. Prognosis is generally favorable. Many of those affected remain asymptomatic and remission often occurs spontaneously, although between 10% and 30% of the patients have chronic disease and permanent deterioration in lung function. Sarcoidosis is caused by an external agent that triggers a characteristic immune response in genetically susceptible individuals. Environmental, occupational, and genetic factors have all been implicated, but research is still in the early stages. Case-control studies, as well as advances in molecular biology, will help to identify genetic susceptibility factors and to understand the different phenotypes of sarcoidosis.

Entities:  

Mesh:

Year:  2007        PMID: 17288898      PMCID: PMC7130812     

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  60 in total

1.  Occupational risk factors for sarcoidosis in African-American siblings.

Authors:  Gena P Kucera; Benjamin A Rybicki; Kandace L Kirkey; Steven W Coon; Marcie L Major; Mary J Maliarik; Michael C Iannuzzi
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

2.  Seasonal occurrence of sarcoidosis in Greece.

Authors:  S Panayeas; P Theodorakopoulos; A Bouras; S Constantopoulos
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

Review 3.  Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.

Authors:  B A Rybicki; M Major; J Popovich; M J Maliarik; M C Iannuzzi
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

4.  A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction.

Authors:  D Bocart; D Lecossier; A De Lassence; D Valeyre; J P Battesti; A J Hance
Journal:  Am Rev Respir Dis       Date:  1992-05

5.  Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).

Authors:  B A Rybicki; M C Iannuzzi; M M Frederick; B W Thompson; M D Rossman; E A Bresnitz; M L Terrin; D R Moller; J Barnard; R P Baughman; L DePalo; G Hunninghake; C Johns; M A Judson; G L Knatterud; G McLennan; L S Newman; D L Rabin; C Rose; A S Teirstein; S E Weinberger; H Yeager; R Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2001-12-01       Impact factor: 21.405

6.  Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation.

Authors:  J Grunewald; J Wahlström; M Berlin; H Wigzell; A Eklund; O Olerup
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

7.  Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising 5536 patients.

Authors:  Keld-Erik Byg; Nils Milman; Stig Hansen
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2003-03       Impact factor: 0.670

8.  Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction.

Authors:  S A Saboor; N M Johnson; J McFadden
Journal:  Lancet       Date:  1992-04-25       Impact factor: 79.321

9.  [Sarcoidosis in a sanitary area at Leon (Spain). Epidemiology and clinical features].

Authors:  M Alcoba Leza; M R Pérez-Simón; J M Guerra Laso; J A Carro Fernández; M A Alonso Fernández; B Blanco Iglesias; P Bueno Suárez; I Muinelo Voces
Journal:  An Med Interna       Date:  2003-12

10.  Two year prognosis of sarcoidosis: the ACCESS experience.

Authors:  Marc A Judson; Robert P Baughman; Bruce W Thompson; Alvin S Teirstein; Michael L Terrin; Milton D Rossman; Henry Yeager; Geoffrey McLennan; Eddy A Bresnitz; Louis DePalo; Gary Hunninghake; Michael C Iannuzzi; Carol J Johns; David R Moller; Lee S Newman; David L Rabin; Cecile Rose; Benjamin A Rybicki; Steven E Weinberger; Genell L Knatterud; Reuben Cherniak
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2003-10       Impact factor: 0.670

View more
  8 in total

Review 1.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

2.  Oral Lesion as the first Clinical Presentation in Sarcoidosis: A Case Report.

Authors:  Abdul Rahman S Al-Azri; Richard M Logan; Alastair N Goss
Journal:  Oman Med J       Date:  2012-05

3.  Sarcoidosis presenting as isolated gingival enlargement: a rare case entity.

Authors:  Pragya Tripathi; Jaihans Aggarwal; Deepak Chopra; Sukhchain Bagga; Kanika Sethi
Journal:  J Clin Diagn Res       Date:  2014-11-20

4.  Use of insurance claims data to determine prevalence and confirm a cluster of sarcoidosis cases in Vermont.

Authors:  Lori A Cragin; A Scott Laney; Cortland J Lohff; Brennan Martin; John A Pandiani; Lynn Z Blevins
Journal:  Public Health Rep       Date:  2009 May-Jun       Impact factor: 2.792

5.  Sarcoidosis in an athlete.

Authors:  Laura Stefani; Ilaria Corsani; Paolo Manetti; Giulio Ciullini; Giorgio Galanti
Journal:  Asian J Sports Med       Date:  2011-03

6.  Sarcoidosis in an Italian province. Prevalence and environmental risk factors.

Authors:  Deborah Beghè; Luca Dall'Asta; Claudia Garavelli; Augusto Alberto Pastorelli; Marilena Muscarella; Gloria Saccani; Marina Aiello; Ernesto Crisafulli; Massimo Corradi; Paolo Stacchini; Alfredo Chetta; Giuseppina Bertorelli
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

Review 7.  Assessment of Experimental Techniques That Facilitate Human Granuloma Formation in an In Vitro System: A Systematic Review.

Authors:  Nirosha Ganesan; Steven Ronsmans; Jeroen Vanoirbeek; Peter H M Hoet
Journal:  Cells       Date:  2022-03-02       Impact factor: 6.600

Review 8.  Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments.

Authors:  Rashi Jain; Dhananjay Yadav; Nidhi Puranik; Randeep Guleria; Jun-O Jin
Journal:  J Clin Med       Date:  2020-04-10       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.